Long-term tolerance and efficacy of siltuximab (anti-IL-6) in a young adult with idiopathic multicentric Castleman disease during COVID-19

Background: Castleman disease (CD) is a rare lymphoproliferative disorder with various subtypes, including the HHV-8-negative/idiopathic multicentric CD (iMCD). The diagnosis of iMCD remains challenging due to its non-specific presentation, in the form of generalised lymphadenopathies and inflammati...

Descripción completa

Detalles Bibliográficos

Autores principales:	Helbies Bedier, Stéphane Isnard, Chelsea Maedler-Kron, Jean-Pierre Routy
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	SMC MEDIA SRL 2023-11-01
Colección:	European Journal of Case Reports in Internal Medicine
Materias:	lymphoproliferative disorders multicentric castleman disease siltuximab il-6 covid-19
Acceso en línea:	https://www.ejcrim.com/index.php/EJCRIM/article/view/4098
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!